JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ESV
2101
DELISTED
Ensco Rowan plc
ESV
| $7.26M | ﹤0.01% |
352,035
-70,971
| -17% | -$2.04M |
2013 Q2
16 quarters
|
|
2102
Amphastar Pharmaceuticals
AMPH
$1.08B
| $7.26M | ﹤0.01% |
406,625
-111,275
| -21% | -$1.76M |
2014 Q3
11 quarters
|
|
|
RATE
2103
DELISTED
Bankrate Inc
RATE
| $7.25M | ﹤0.01% |
564,593
+220,712
| +64% | +$2.37M |
2016 Q4
2 quarters
|
|
2104
Pan American Silver
PAAS
$18.8B
| $7.25M | ﹤0.01% |
431,069
+353,037
| +452% | +$6.1M |
2014 Q1
13 quarters
|
|
2105
Yelp
YELP
$1B
| $7.24M | ﹤0.01% |
241,193
+226,740
| +1,569% | +$7.07M |
2013 Q2
16 quarters
|
|
2106
First Community Bankshares
FCBC
$905M
| $7.23M | ﹤0.01% |
264,357
-15,354
| -5% | -$400K |
2013 Q2
16 quarters
|
|
2107
Invesco Variable Rate Preferred ETF
VRP
$3B
| $7.2M | ﹤0.01% |
275,339
+115,135
| +72% | +$2.98M |
2016 Q2
4 quarters
|
|
2108
CALL
Vodafone
VOD
$38.9B
| $7.18M | ﹤0.01% |
250,000
-52,200
| -17% | -$1.45M |
2017 Q1
1 quarter
|
|
2109
PUT
Exelixis
EXEL
$14.6B
| $7.14M | ﹤0.01% |
290,000
-69,000
| -19% | -$1.46M |
2016 Q4
2 quarters
|
|
2110
Group 1 Automotive
GPI
$2.88B
| $7.14M | ﹤0.01% |
112,808
+7,446
| +7% | +$478K |
2013 Q2
16 quarters
|
|
|
EVHC
2111
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $7.14M | ﹤0.01% |
113,879
+49,479
| +77% | +$2.85M |
2013 Q3
15 quarters
|
|
|
AXAS
2112
DELISTED
Abraxas Petroleum Corp
AXAS
| $7.13M | ﹤0.01% |
220,151
-3,064
| -1% | -$115K |
2016 Q4
2 quarters
|
|
2113
Cartesian Therapeutics
RNAC
$216M
| $7.13M | ﹤0.01% |
11,962
+3,816
| +47% | +$1.69M |
2016 Q2
4 quarters
|
|
|
AKRX
2114
CALL
DELISTED
Akorn Inc
AKRX
| $7.12M | ﹤0.01% |
212,400
+173,641
| +448% | +$5.65M |
2017 Q1
1 quarter
|
|
|
NXRT
2115
NexPoint Residential Trust
NXRT
$475M
| $7.12M | ﹤0.01% |
285,915
-44,932
| -14% | -$1.12M |
2015 Q4
6 quarters
|
|
|
BSMX
2116
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $7.12M | ﹤0.01% |
738,423
+525,642
| +247% | +$4.87M |
2016 Q1
5 quarters
|
|
|
SCLN
2117
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $7.11M | ﹤0.01% |
646,433
-38,229
| -6% | -$382K |
2015 Q4
6 quarters
|
|
2118
iShares MSCI United Kingdom ETF
EWU
$3.65B
| $7.11M | ﹤0.01% |
213,204
+197,558
| +1,263% | +$6.64M |
2013 Q4
14 quarters
|
|
|
DBRG
2119
DELISTED
DigitalBridge
DBRG
| $7.1M | ﹤0.01% |
125,937
-47,171
| -27% | -$2.56M |
2014 Q3
11 quarters
|
|
2120
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$414M
| $7.1M | ﹤0.01% |
296,159
+152,577
| +106% | +$3.59M |
2016 Q3
3 quarters
|
|
2121
PUT
Simon Property Group
SPG
$65.2B
| $7.08M | ﹤0.01% |
+43,800
| New | +$7.13M |
2017 Q2
0 quarters
|
|
|
EDR
2122
DELISTED
Education Realty Trust Inc
EDR
| $7.07M | ﹤0.01% |
182,466
-66,242
| -27% | -$2.59M |
2013 Q2
16 quarters
|
|
2123
CALL
Thermo Fisher Scientific
TMO
$250B
| $7.07M | ﹤0.01% |
40,500
+2,400
| +6% | +$403K |
2017 Q1
1 quarter
|
|
|
TUP
2124
DELISTED
Tupperware Brands Corporation
TUP
| $7.06M | ﹤0.01% |
100,490
+22,338
| +29% | +$1.56M |
2013 Q2
16 quarters
|
|
2125
IQVIA
IQV
$43.8B
| $7.05M | ﹤0.01% |
78,832
+58,821
| +294% | +$4.97M |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.